Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation

Affiliations

¹ Children's Hospital, University of Cologne, Cologne, Germany. frank.berthold@uk-koeln.de.
² Institute of Medical Statistics and Bioinformatics, University of Cologne, Cologne, Germany.
³ Children's Hospital, University of Cologne, Cologne, Germany.
⁴ Children's Hospital, University of Frankfurt, Frankfurt, Germany.
⁵ Children's Hospital, University of Essen, Essen, Germany.
⁶ Children's Hospital, Olgahospital, Stuttgart, Germany.

Published Erratum

Frank Berthold et al. Br J Cancer. 2019 Nov.

. 2019 Nov;121(10):894-895.

doi: 10.1038/s41416-019-0592-5.

¹ Children's Hospital, University of Cologne, Cologne, Germany. frank.berthold@uk-koeln.de.
² Institute of Medical Statistics and Bioinformatics, University of Cologne, Cologne, Germany.
³ Children's Hospital, University of Cologne, Cologne, Germany.
⁴ Children's Hospital, University of Frankfurt, Frankfurt, Germany.
⁵ Children's Hospital, University of Essen, Essen, Germany.
⁶ Children's Hospital, Olgahospital, Stuttgart, Germany.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.
Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T. Berthold F, et al. Br J Cancer. 2018 Aug;119(3):282-290. doi: 10.1038/s41416-018-0169-8. Epub 2018 Jul 11. Br J Cancer. 2018. PMID: 29991700 Free PMC article. Clinical Trial.